Home
  >  
Section 40
  >  
Chapter 39,907

Effect of adrenergic and cholinergic antagonists on post-hemorrhagic erythropoiesis in rats

Chakrabarty, A.S.; Morankar, M.D.; Srinivasan, V.; Chakrabarty, K.

Indian Journal of Experimental Biology 27(1): 85-86

1989

ISSN/ISBN: 0019-5189
PMID: 2606528
Accession: 039906028
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Experiments were carried out in albino rats to find out the effect of propranolol, priscol and atropine on post-hemorrhagic erythropoiesis. Administration of either propranolol or priscol decreased reticulocyte response following hemorrhage, whereas administration of atropine produced no change. The results indicate that alpha as well as beta adrenergic systems participate in the control of erythropoiesis following hemorrhage, whereas parasympathetic system does not take part.

Full Text Article emailed within 1 workday: $29.90




Related References

Bugajski, J.; Gadek, A. 1984: The effect of adrenergic and cholinergic antagonists on central histaminergic stimulation of pituitary-adrenocortical response under stress in rats Neuroendocrinology 38(6): 447-452
Kouchi, K.; Nagai, R.; Nagata, S.; Oka, M. 1999: Pharmacodynamic studies on adrenergic and cholinergic receptor antagonists with Wavelet analysis of blood pressure fluctuation in conscious rats Japanese Journal of Pharmacology 79(Suppl 1): 109P
Asztély, A.; Tobin, G.; Ekström, J. 1994: Parasympathetic non-adrenergic, non-cholinergic reflex secretion of parotid acinar granules in rats pretreated with atropine and adrenoceptor antagonists Regulatory Peptides 51(3): 255-262
Saber, A.J.; Cain, D.P. 2003: Combined β-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: Implications for Alzheimer disease and pharmacotherapy with β-adrenergic antagonists Neuropsychopharmacology (New York) 28(7): 1247-1256
Saber, A.J.; Cain, D.P. 2003: Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 28(7): 1247-1256
Irie, K.; Nomoto, T.; Muraki, T.; Furukawa, K. 1990: Postganglionic neurons in duodenum are non adrenergic non cholinergic in adult rats while they are cholinergic in neonates European Journal of Pharmacology 183(6): 2193
Boggs, D.R.; Geist, A.; Chervenick, P.A. 1969: Contribution of the mouse spleen to post-hemorrhagic erythropoiesis Life Sciences 8(11): 587-599
Sanford, L.D.; Yang, L.; Tang, X.; Dong, E.; Ross, R.J.; Morrison, A.R. 2006: Cholinergic regulation of the central nucleus of the amygdala in rats: effects of local microinjections of cholinomimetics and cholinergic antagonists on arousal and sleep Neuroscience 141(4): 2167-2176
Grant, W.C.; Root, W.S. 1947: The relation of O2 in bone marrow blood to post-hemorrhagic erythropoiesis American Journal of Physiology 150(4): 618-627
Dren, A.T.; Domino, E.F. 1968: Cholinergic and adrenergic activating agents as antagonists of the EEG effects of hemicholinium-3 Archives Internationales de Pharmacodynamie et de Therapie 175(1): 63-72
Ellis, J.L.; Farmer, S.G. 1988: Effects of vip antagonists and vip and phi antisera on non adrenergic non cholinergic tracheal relaxation British Journal of Pharmacology 95(Suppl): 508P
Dorinovskaya, A.P. 1958: The effect of drug-induced sleep on erythropoiesis during a post-hemorrhagic period Russian and English Summ Fiziol Zhur 4(3): 339-347
Barbosa, S.P.; Saad, W.A.; Camargo, L.A.A.; Renzi, A.; De LucaL.A.Jr.; Silveira, J.E.N.; Menani, J.V. 1993: Role of cholinergic and adrenergic pathways of the medial septal area on the pressor and dipsogenic responses induced by central cholinergic activation and angiotensin II in rats Society for Neuroscience Abstracts 19(1-3): 1240
Schauenstein, K.; Felsner, P.; Rinner, I.; Liebmann, P.M.; Stevenson, J.R. 1999: In vivo immunomodulation by peripheral adrenergic and cholinergic agonist/antagonists in the rat model Neuroimmunomodulation 6(6): 413
Narioka, J.; Ohashi, Y. 2007: Effects of adrenergic and cholinergic antagonists on diameter of nasolacrimal drainage system Graefe's Archive for Clinical and Experimental Ophthalmology 245(12): 1843-1850
Luchette, F.A.; Robinson, B.R.; Friend, L.A.; McCarter, F.; Frame, S.B.; James, J.H. 1999: Adrenergic antagonists reduce lactic acidosis in response to hemorrhagic shock Journal of Trauma 46(5): 873-880
Schauenstein, K.; Rinner, I.; Felsner, P.; Liebmann, P.M.; Stevenson, J.R.; Westermann, J.; Haas, H.S.; Cohen, R.L.; Chambers, D.A. 2001: Peripheral immunoregulation by adrenergic and cholinergic agonists/antagonists as studied in animal models Sperner-Unterweger, Barbara, Fleischhacker, W Wolfgang, Kaschka, W P Advances in Biological Psychiatry Psychoneuroimmunology: Hypotheses and current research 1-6
Sanghvi, I.S. 1967: Effects of cholinergic and adrenergic agents and their antagonists at the neuromuscular junction of the cat extraocular muscles Investigative Ophthalmology 6(3): 269-276
Schauenstein, K.; Felsner, P.; Rinner, I.; Liebmann, P.M.; Stevenson, J.R.; Westermann, J.; Haas, H.S.; Cohen, R.L.; Chambers, D.A. 2000: In vivo immunomodulation by peripheral adrenergic and cholinergic agonists/antagonists in rat and mouse models Annals of the new York Academy of Sciences 917: 618-627
Benkó, R.; Undi, S.; Wolf, M.; Vereczkei, A.; Illényi, L.; Kassai, M.; Cseke, L.; Kelemen, D.; Horváth, O.P.; Antal, A.; Magyar, K.; Barthó, L. 2007: P2 purinoceptor antagonists inhibit the non-adrenergic, non-cholinergic relaxation of the human colon in vitro Neuroscience 147(1): 146-152